Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 54Neoplasms 38Lung Neoplasms 25Colorectal Neoplasms 24Prostatic Neoplasms 17Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Pancreatic Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Hematologic Neoplasms 9Anxiety Disorders 9Urinary Bladder Neoplasms 8Obesity 8Melanoma 8Lymphoma 8Depression 8Ovarian Neoplasms 7Endometrial Neoplasms 7Vulvar Neoplasms 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Sarcoma 5Papillomavirus Infections 5Pain 5Leukemia, Myeloid, Acute 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4

Interventions

Methods 1Immunotherapy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Cancer Liver Metastases × Methods × Clear all
NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Shandong Provincial Hospital

Phase 2 Not yet recruiting
38 enrolled
Gastrointestinal

Pancreatic Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡